Showing results (821-830 of 853) with videos related to
Sort By:
Pageof 86
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2025
SARS-CoV-2-derived RNA replicons as safe and effective vaccinesMarta Villarejo-Torres, Iván Nombela-Diaz, Diego Muñóz-Santos, et al.Nature Communications|February 9, 2022
Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong KongHaogao Gu, Ruopeng Xie, Dillon C Adam, et al.Nature Microbiology|October 27, 2021
Ancestral sequence reconstruction pinpoints adaptations that enable avian influenza virus transmission in pigsWen Su, Rhodri Harfoot, Yvonne C F Su, et al.Proceedings of the National Academy of Sciences of the United States of America|January 18, 2023
Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2Donglan Liu, Chunke Chen, Dingbin Chen, et al.Frontiers in Immunology|March 23, 2023
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescentsDaniel Leung, Carolyn A Cohen, Xiaofeng Mu, et al.Cell Reports|January 4, 2024
Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domainYanqun Wang, Zhaoyong Zhang, Minnan Yang, et al.The Lancet. Microbe|August 7, 2023
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trialNancy H L Leung, Samuel M S Cheng, Carolyn A Cohen, et al.Science (New York, N.Y.)|August 14, 2020
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humansPrabhu S Arunachalam, Florian Wimmers, Chris Ka Pun Mok, et al.Plos One|February 28, 2015
Clinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in Guangdong provinceZi Feng Yang, Chris Ka Pun Mok, Xiao Qing Liu, et al.Plos Pathogens|January 13, 2022
Advances and gaps in SARS-CoV-2 infection modelsCésar Muñoz-Fontela, Lina Widerspick, Randy A Albrecht, et al.Pageof 86